CORGARD TAB 40MG 40 MG
NADOLOL : 40 MG · DIN 00607126 · BRISTOL-MYERS SQUIBB CANADA
Health Canada status: CANCELLED POST MARKET
What is CORGARD TAB 40MG?
CORGARD TAB 40MG 40 MG contains NADOLOL : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 00607126, held by BRISTOL-MYERS SQUIBB CANADA, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 29-May-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CORGARD TAB 40MG used for?
Prophylaxis of angina pectoris. Management of mild or moderate hypertension.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00607126 |
|---|---|
| Brand name | CORGARD TAB 40MG |
| Generic / active ingredient | NADOLOL : 40 MG |
| Manufacturer | BRISTOL-MYERS SQUIBB CANADA |
| Strength | 40 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AA12 NADOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-May-2006 |
| Original market date | 1984-12-31 00:00:00 |
How is it administered?
Administered as a single daily dose. Angina: Start 80 mg/day, increase by 80 mg weekly; max 240 mg. Hypertension: Start 80 mg/day, increase by 80 mg weekly; max 320 mg.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store tightly closed, at room temperature (15-30°C). Protect from heat, light and moisture.
How is it supplied?
Blister packages of 28 tablets; bottles of 100, 500 (40 mg), and 1000 (80 mg) tablets.
Contraindications
Allergic rhinitis, bronchospasm, asthma, severe COPD, sinus bradycardia, 2nd/3rd degree AV block, right ventricular failure, CHF, cardiogenic shock, anesthesia with myocardial depressants.
Warnings and precautions
Risk of cardiac failure. Abrupt cessation can exacerbate angina or cause MI. May mask hypoglycemia or thyrotoxicosis. Oculomucocutaneous syndrome risk.
What can be used instead?
Other Canadian products sharing ATC code C07AA12 NADOLOL. 5 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-NADOLOL | 160 MG | TABLET | APOTEX INC | MARKETED | DIN 00782475 |
| APO-NADOLOL | 40 MG | TABLET | APOTEX INC | MARKETED | DIN 00782505 |
| APO-NADOLOL | 80 MG | Tablet | APOTEX INC | MARKETED | DIN 00782467 |
| MINT-NADOLOL | 40 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02496380 |
| MINT-NADOLOL | 80 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02496399 |
| CORGARD TAB 160MG | 160 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 00523372 |
| CORGARD TAB 80MG | 80 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 00463256 |
| NADOLOL-160 TAB 160MG | 160 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00818720 |
| NADOLOL-40 TAB 40MG | 40 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00828815 |
| NADOLOL-80 TAB 80MG | 80 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00818704 |
Who else supplies NADOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NADOLOL appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.